scorecardresearchSuven Pharmaceuticals Share Price Live NSE, BSE, Today - Suven Pharmaceuticals

Suven Pharmaceuticals

BSE: 543064 | NSE: SUVENPHAR | ISIN: INE03QK01018 | SECTOR: Biotechnology & Drugs

663.85 -0.70 (-0.11%)

28 Feb 2024, 04:11 (IST)
  • Open

    653.65
  • High

    674.00
  • Low

    653.65
  • Prev Close

    664.55
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    168.99B
  • Volume

    7.07K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    663.10
  • Ask

    664.30

Company Description

  • Biotechnology & Drugs
  • BSE

    543064
  • NSE

    SUVENPHAR
  • ISIN

    INE03QK01018

Suven Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies. The Company operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe, and others. In India, the Company sells bulk drugs and intermediates, chemicals, and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In other countries, the Company sells bulk drugs, intermediates, and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.

Company Officers

  • Vaidheesh Annaswamy

    Executive Chairman of the Board
  • Sudhir Singh

    Chief Executive Officer
  • Himanshu Agarwal

    Chief Financial Officer
  • Gaurav Bahadur

    Chief Human Resource Officer
  • K. Rao

    Compliance Officer, Company Secretary
  • Vetukuri Venkata Prasada Raju

    Managing Director, Additional Executive Director
  • Subba Komaravolu

    Chief Strategy Officer
  • Brian Shaughnessy

    Chief Commercial Officer